2月16日,10X Genomics, Inc.(TXG.US)公布财报,公告显示公司2024财年净利润为-1.83亿美元,同比增加28.24%;其中营业收入为6.11亿美元,同比减少1.29%,每股基本收益为-1.52美元。从资产负债表来看,10X Genomics, Inc.(TXG.US)总负债2.09亿美元,其中短期债务9.29百万美元,资产负债比为4.40,流动比率为4.95。机构评级:...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.